University of Oulu

Gomes, C.P.C.; Ágg, B.; Andova, A.; Arslan, S.; Baker, A.; Barteková, M.; Beis, D.; Betsou, F.; Bezzina Wettinger, S.; Bugarski, B.; Condorelli, G.; da Silva, G.J.J.; Danilin, S.; de Gonzalo-Calvo, D.; Buil, A.; Carmo-Fonseca, M.; Enguita, F.J.; Felekkis, K.; Ferdinandy, P.; Gyöngyösi, M.; Hackl, M.; Karaduzovic-Hadziabdic, K.; Hellemans, J.; Heymans, S.; Hlavackova, M.; Hoydal, M.A.; Jankovic, A.; Jusic, A.; Kardassis, D.; Kerkelä, R.; Kuster, G.M.; Lakkisto, P.; Leszek, P.; Lustrek, M.; Maegdefessel, L.; Martelli, F.; Novella, S.; O’Brien, T.; Papaneophytou, C.; Pedrazzini, T.; Pinet, F.; Popescu, O.; Potočnjak, I.; Robinson, E.; Sasson, S.; Scholz, M.; Simionescu, M.; Stoll, M.; Varga, Z.V.; Vinciguerra, M.; Xuereb, A.; Yilmaz, M.B.; Emanueli, C.; Devaux, Y. Catalyzing Transcriptomics Research in Cardiovascular Disease: The CardioRNA COST Action CA17129. Non-Coding RNA 2019, 5, 31.

Catalyzing transcriptomics research in cardiovascular disease : the CardioRNA COST Action CA17129

Saved in:
Author: Gomes, Clarissa Pedrosa da Costa1; Agg, Bence2; Andova, Andrejaana3;
Organizations: 1Luxembourg Inst Hlth, Cardiovasc Res Unit, L-1445 Strassen, Luxembourg.
2Semmelweis Univ, Dept Pharmacol & Pharmacotherapy, H-1085 Budapest, Hungary.
3Jozef Stefan Inst, Dept Intelligent Syst, Ljubljana 1000E, Slovenia.
4Cumhuriyet Univ, Fac Med, Dept Med Biol, TR-58140 Sivas, Turkey.
5Univ Edinburgh, Ctr Cardiovasc Sci, Queens Med Res Inst, Edinburgh EH16 4TJ, Midlothian, Scotland.
6Slovak Acad Sci, Ctr Expt Med, Inst Heart Res, Bratislava 84104, Slovakia.
7Acad Athens, Biomed Res Fdn, Athens 11527, Greece.
8Integrated BioBank Luxembourg, L-3550 Dudelange, Luxembourg.
9Univ Malta, Fac Hlth Sci, MSD-2080 Msida, Malta.
10Univ Belgrade, Fac Technol & Met, Belgrade 11000, Serbia.
11Humanitas Res Hosp, Dept Cardiovasc, I-20089 Rozzano, Italy.
12Oslo Univ Hosp, Inst Expt Med Res, PB 4956 Nydalen, NO-0424 Oslo, Norway.
13Univ Oslo, PB 4956 Nydalen, NO-0424 Oslo, Norway.
14Firalis, F-68330 Huningue, France.
15CSIC, Inst Biomed Res Barcelona IIBB, Barcelona 08036, Spain.
16Mental Hlth Ctr Sct Hans, DK-4000 Roskilde, Denmark.
17Univ Lisbon, Fac Med, Inst Med Mol, P-1649028 Lisbon, Portugal.
18Univ Nicosia, Sch Sci & Engn, Dept Life & Hlth Sci, CY-2417 Nicosia, Cyprus.
19Med Univ Vienna, Dept Cardiol, A-1090 Vienna, Austria.
20TAmiRNA, A-1190 Vienna, Austria.
21Int Univ Sarajevo, Fac Engn & Nat Sci, Sarajevo 71210, Bosnia & Herceg.
22Biogazelle, B-9052 Zwijnaarde, Belgium.
23Maastricht Univ, Fac Hlth Med & Life Sci, Sch Cardiovasc Dis, NL-6229 ER Maastricht, Netherlands.
24Czech Acad Sci, Inst Physiol, Dept Dev Cardiol, Prague 14220, Czech Republic.
25NTNU Norwegian Univ Technol & Sci, Fac Med & Hlth Sci, Dept Circulat & Med Imaging, NO-7489 Trondheim, Norway.
26Univ Belgrade, Inst Biol Res Sinisa Stankovic, Dept Physiol, Belgrade 11000, Serbia.
27Univ Tuzla, Fac Nat Sci & Math, Dept Biol, Tuzla 75000, Bosnia & Herceg.
28Univ Crete, Med Sch, Dept Basic Sci, Iraklion 71003, Crete, Greece.
29Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion 71003, Crete, Greece.
30Univ Oulu, Res Unit Biomed, Oulu 90014, Finland.
31Univ Hosp, Dept Biomed & Clin Cardiol, CH-4031 Basel, Switzerland.
32Univ Basel, CH-4031 Basel, Switzerland.
33Minerva Fdn, Helsinki 00290, Finland.
34Cardinal Stefan Wyszynski Inst Cardiol, PL-04628 Warsaw, Poland.
35Karolinska Inst, Ctr Mol Med, S-17176 Stockholm, Sweden.
36IRCCS Policlin San Donato, Mol Cardiol Lab, I-20097 Milan, Italy.
37Univ Valencia, Dept Physiol, Valencia 46010, Spain.
38INCLIVA Biomed Res Inst INCLIVA, Valencia 46010, Spain.
39Natl Univ Ireland Galway, Regenerat Med Inst REMEDI, Galway H91 TK33, Ireland.
40Univ Lausanne, Med Sch, Dept Cardiovasc Med, Expt Cardiol Unit,Div Cardiol, CH-1011 Lausanne, Switzerland.
41Inst Pasteur, INSERM, F-59019 Lille, France.
42Babes Bolyai Univ, Cluj Napoca 400084, Romania.
43Univ Hosp Ctr Sisters Char, Inst Clin Med Res & Educ, Zagreb 10000, Croatia.
44Maastricht Univ, Fac Hlth Med & Life Sci, Ctr Heart Failure Res, Dept Cardiol, NL-6229 ER Maastricht, Netherlands.
45Hebrew Univ Jerusalem, Fac Med, Inst Drug Res, IL-91120 Jerusalem, Israel.
46Univ Leipzig, Med Fac, Inst Med Informat Stat & Epidemiol, D-04107 Leipzig, Germany.
47Inst Cellular Biol & Pathol Nicolae Simionescu, Bucharest 050568, Romania.
48Westfalische Wilhelms Univ Munster, Inst Human Genet, Dept Genet Epidemiol, D-48149 Munster, Germany.
49Int Clin Res Ctr, Brno 65691, Czech Republic.
50Dokuz Eylul Univ, Fac Med, Dept Cardiol, TR-35340 Izmir, Turkey.
51Imperial Coll London, Fac Med, Natl Heart & Lung Inst, London W12 0HH, England.
Format: article
Version: published version
Access: open
Online Access: PDF Full Text (PDF, 1.1 MB)
Persistent link:
Language: English
Published: Multidisciplinary Digital Publishing Institute, 2019
Publish Date: 2020-03-12


Cardiovascular disease (CVD) remains the leading cause of death worldwide and, despite continuous advances, better diagnostic and prognostic tools, as well as therapy, are needed. The human transcriptome, which is the set of all RNA produced in a cell, is much more complex than previously thought and the lack of dialogue between researchers and industrials and consensus on guidelines to generate data make it harder to compare and reproduce results. This European Cooperation in Science and Technology (COST) Action aims to accelerate the understanding of transcriptomics in CVD and further the translation of experimental data into usable applications to improve personalized medicine in this field by creating an interdisciplinary network. It aims to provide opportunities for collaboration between stakeholders from complementary backgrounds, allowing the functions of different RNAs and their interactions to be more rapidly deciphered in the cardiovascular context for translation into the clinic, thus fostering personalized medicine and meeting a current public health challenge. Thus, this Action will advance studies on cardiovascular transcriptomics, generate innovative projects, and consolidate the leadership of European research groups in the field. COST (European Cooperation in Science and Technology) is a funding organization for research and innovation networks (

see all

Series: Non-coding RNA
ISSN: 2311-553X
ISSN-E: 2311-553X
ISSN-L: 2311-553X
Volume: 5
Issue: 2
Article number: 31
DOI: 10.3390/ncrna5020031
Type of Publication: A1 Journal article – refereed
Field of Science: 3111 Biomedicine
Funding: This work is supported by COST (European Cooperation in Science and Technology) Action EU-CardioRNA CA17129. YD is the chair and CE is the vice-chair of the European COST Action CA17129, CardioRNA.
Copyright information: © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (